Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Stack

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of the American College of Cardiology|March 1, 1993
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study GroupT C Wall, R M Califf, S G Ellis, et al.
The American Journal of Cardiology|May 12, 1998
A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary interventionJ B Pracyk, T C Wall, J P Longabaugh, et al.
Journal of the American College of Cardiology|September 1, 1990
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosisC M O'Connor, R M Califf, E W Massey, et al.
The American Journal of Cardiology|April 1, 1988
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Journal of the American College of Cardiology|May 1, 1988
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarctionD J Kereiakes, E J Topol, B S George, et al.
American Heart Journal|August 1, 1989
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.
North Carolina Medical Journal|December 1, 1991
From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart CenterM W Krucoff, M B Higginbotham, P Van Trigt, et al.
Journal of the American College of Cardiology|February 1, 1991
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|June 1, 1988
Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarctionR S Stack, R M Califf, T Hinohara, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of the American College of Cardiology|March 1, 1993
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study GroupT C Wall, R M Califf, S G Ellis, et al.
The American Journal of Cardiology|May 12, 1998
A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary interventionJ B Pracyk, T C Wall, J P Longabaugh, et al.
Journal of the American College of Cardiology|September 1, 1990
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosisC M O'Connor, R M Califf, E W Massey, et al.
The American Journal of Cardiology|April 1, 1988
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Journal of the American College of Cardiology|May 1, 1988
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarctionD J Kereiakes, E J Topol, B S George, et al.
American Heart Journal|August 1, 1989
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.
North Carolina Medical Journal|December 1, 1991
From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart CenterM W Krucoff, M B Higginbotham, P Van Trigt, et al.
Journal of the American College of Cardiology|February 1, 1991
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|June 1, 1988
Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarctionR S Stack, R M Califf, T Hinohara, et al.
Pageof 11